A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Pancreatic steatosis is a risk factor for pancreatic cysts among patients with diabetes
Tekijät: Käräjämäki, Aki J.; Johansson, Katarina; Laitinen, Aleksi; Häggblom, Jenny; Käräjämäki, Annemari; Tuomi, Tiinamaija
Kustantaja: Taylor & Francis
Julkaisuvuosi: 2026
Lehti: Scandinavian Journal of Gastroenterology
ISSN: 0036-5521
eISSN: 1502-7708
DOI: https://doi.org/10.1080/00365521.2026.2632062
Julkaisun avoimuus kirjaamishetkellä: Ei avoimesti saatavilla
Julkaisukanavan avoimuus : Osittain avoin julkaisukanava
Verkko-osoite: https://doi.org/10.1080/00365521.2026.2632062
Objectives
To investigate whether pancreatic steatosis is associated with the presence of pancreatic cysts among individuals with diabetes.
Material and Methods158 individuals [mean age 66 ± 10 years, 81 (51%) female] with diabetes [135 (85%) had type 2 diabetes] participated in the study involving Magnetic Resonance Imaging (MRI), blood tests and anthropometric measurements. Pancreatic steatosis was estimated qualitatively by a radiologist as well as using the pancreatic fat fraction.
ResultsOf 158 study participants, 78 (49%) had pancreatic cysts. The individuals with pancreatic cysts were older than those without cysts (69 ± 7 years vs. 63 ± 12 years, p = 0.002). Compared to the individuals without pancreatic cysts, those with pancreatic cysts had more often pancreatic steatosis (46 (59%) vs. 31 (39%), p = 0.011) and a higher pancreatic fat fraction (13% ± 10% vs. 9% ± 8%, p = 0.021). Likewise, the Odds Ratio (OR) for the presence of pancreatic cysts was 1.043 [95% confidence interval 1.007–1.082, p = 0.020] for pancreatic fat fraction and 2.272 [1.202–4.297, p = 0.012] pancreatic steatosis. The statistically significant association remained even after correction for multiple possible confounding factors (OR 1.045 [1.003–1.089, p = 0.035], and OR 2.588 [1.182–5.667, p = 0.017], respectively).
ConclusionsPancreatic steatosis and older age are independently associated with the presence of pancreatic cysts in patients with diabetes. Despite some potential mechanistic links, prospective studies are needed to examine the possible causality.
Julkaisussa olevat rahoitustiedot:
The Direva Study has been supported by the Vasa Hospital District, Ollqvist Foundation, State Research Funding via the Turku University Hospital, Vasa Central Hospital, Jakobstadsnejdens Heart Foundation, the Medical Foundation of Vaasa and the Finnish Medical Foundation. The study (TT) has also been supported by grants from the Folkhälsan Research Foundation, the Sigrid Juselius Foundation, The Academy of Finland, University of Helsinki, Swedish Cultural Foundation in Finland, Finnish Diabetes Research Foundation, Foundation for Life and Health in Finland, Finnish Medical Society, Novonordisk Foundation, and State Research Funding via the Helsinki University Hospital. AK has received personal support by Vaasa Medical Foundation and Wellbeing Services Area of Osthrobotnia. KJ has received personal support by Finska Läkaresällskapet. AL has received personal support by Vaasa Medical Foundation, The Finnish Medical Foundation, Turunmaa Duodecim Foundation, Onni & Hilja Tuovinen Foundation, Jussi Lalli & Eeva Mariapori-Lalli Foundation and Kyllikki & Uolevi Lehikoinen Foundation.